---
layout: post
title: "Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments"
date: 2026-02-05 19:01:26 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-24107
original_published: 2022-11-07 00:00:00 +0000
significance: 8.00
---

# Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments

**Published:** February 05, 2026 19:01 UTC
**Source:** Federal Register
**Original Published:** November 07, 2022 00:00 UTC
**Document Number:** 2022-24107

## Summary

The United States Patent and Trademark Office (USPTO), Department of Commerce, in collaboration with the United States Food and Drug Administration (FDA), Department of Health and Human Services, is announcing a public listening session on January 19, 2023, titled "Listening Session on Joint USPTO-FDA Collaboration Initiatives." The purpose of the listening session is to seek public comments on proposed initiatives for collaboration between the agencies to advance President Biden's Executive Order on "Promoting Competition in the American Economy" and to promote greater access to medicines for American families. To assist in gathering public input, the USPTO and the FDA are announcing the establishment of a docket to track feedback received through this notice and a request for comments on these collaborative efforts.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/11/07/2022-24107/joint-uspto-fda-collaboration-initiatives-notice-of-public-listening-session-and-request-for)
- API: https://www.federalregister.gov/api/v1/documents/2022-24107

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
